Yet another Acceleron investor challenges Merck’s $11.5B acquisition offer: Bloomberg aliu Wed, 11/03/2021 – 11:51 More: Yet another Acceleron investor challenges Merck’s .5B acquisition offer: Bloomberg Source: fierce
read moreAfter a phase of slower growth, Novo Nordisk sees the fruits of its Wegovy and Rybelsus launches, CEO says esagonowsky Wed, 11/03/2021 – 11:30 More: After a phase of slower growth, Novo Nordisk sees the fruits of its Wegovy and
read moreIncyte investigates all batches of new eczema cream Opzelura after reports of ‘texture problem’ aliu Wed, 11/03/2021 – 10:53 More: Incyte investigates all batches of new eczema cream Opzelura after reports of 'texture problem' Source: fierce
read moreMerck will support Saudi Arabia effort to build biologics manufacturing operations jkeenan Wed, 11/03/2021 – 10:25 More: Merck will support Saudi Arabia effort to build biologics manufacturing operations Source: fierce
read moreAmgen’s Lumakras off to a strong start toward analyst’s blockbuster predictions pegged to combo potential kdunleavy Wed, 11/03/2021 – 10:16 More: Amgen's Lumakras off to a strong start toward analyst's blockbuster predictions pegged to combo potential Source: fierce
read moreDunad will apply its own platform to generate the novel covalent and targeted protein degrading small molecule drugs More: Novartis signs .3bn deal with UK-based Dunad Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals